Silvernanoparticle-induced hemolysis confounded with direct antiglobulin test-negative autoimmune hemolytic anemias diagnosis

被引:3
作者
Ringel, Frauke [1 ,2 ]
Kiesewetter, Holger [2 ]
Mayer, Beate [3 ]
Bartolmas, Thilo [3 ]
Sehouli, Jalid [1 ]
Salama, Abdulgabar [1 ,2 ]
机构
[1] Charite Univ Med Berlin, Klin Gynakol, Zentrum Onkol Chirurg CVK, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Hamostaseologicum Mine, Medicover, Berlin, Germany
[3] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany
关键词
DAT-negative AIHA; eryptosis; hemolysis; rituximab; silvernanoparticles;
D O I
10.1111/trf.17172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background We describe here the first patient with recurrent hemolysis related to disinfectant containing silver nanoparticles (AgNps). Methods A 58-year-old chemist repeatedly experienced DAT-negative (Coombs-negative) hemolysis during the last 5 years. He was treated with a number of immunosuppressive drugs including 18 times rituximab. The attempt to treat him with cyclosporine A served only to increase the rate of hemolysis. Only by chance, we revealed that the patient regularly used a hand disinfectant containing AgNps. Serological testing was performed using standard techniques. Eryptosis was measured by binding annexin to exposed phosphatidylserine (PS) of the circulating red blood cells (RBCs). Results Antiglobulin tests remained negative, and PS exposing RBCs were detected two times during the last hemolytic episodes. Hemolysis completely disappeared following discontinuation of AgNp containing products. Conclusion AgNps are increasingly being used in a large variety of products. Recently, it was reported that they induce in vitro prohemolytic and procoagulant effects via oxidative stress and eryptosis. The clinical findings imply the hemolysis was provoked by the patient's regular use of cleansing products containing AgNps. Our finding might help to explain the etiology of hemolytical disorders that may remain obscure in many cases.
引用
收藏
页码:2648 / 2652
页数:5
相关论文
共 21 条
[1]  
AZUMA E, 1995, BONE MARROW TRANSPL, V16, P321
[2]   New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy [J].
Barcellini, Wilma ;
Zaninoni, Anna ;
Giannotta, Jun Alessandro ;
Fattizzo, Bruno .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) :1-19
[3]   Paradoxical findings in direct antiglobulin test and classification of agglutinating autoantibodies using eluates and monospecific anti-human globulin sera [J].
Bartolmaes, T. ;
Mayer, B. ;
Yuerek, S. ;
Genth, R. ;
Salama, A. .
VOX SANGUINIS, 2015, 108 (01) :58-63
[4]   Eryptosis in autoimmune haemolytic anaemia [J].
Bartolmaes, Thilo ;
Mayer, Beate ;
Balola, Abdelwahab H. ;
Salama, Abdulgabar .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (01) :36-44
[5]   How I treat cold agglutinin disease [J].
Berentsen, Sigbjorn .
BLOOD, 2021, 137 (10) :1295-1303
[7]   Health Impact of Silver Nanoparticles: A Review of the Biodistribution and Toxicity Following Various Routes of Exposure [J].
Ferdous, Zannatul ;
Nemmar, Abderrahim .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
[8]   The in Vitro Effect of Polyvinylpyrrolidone and Citrate Coated Silver Nanoparticles on Erythrocytic Oxidative Damage and Eryptosis [J].
Ferdous, Zannatul ;
Beegam, Sumaya ;
Tariq, Saeed ;
Ali, Badreldin H. ;
Nemmar, Abderrahim .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) :1577-1588
[9]   Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment [J].
Hill, Quentin A. ;
Hill, Anita ;
Berentsen, Sigbjorn .
BLOOD ADVANCES, 2019, 3 (12) :1897-1906
[10]  
Kaushansky K., 2021, Williams hematology